OPTN
OptiNose Inc

2,017
Mkt Cap
$97.22M
Volume
860,961.00
52W High
$20.03
52W Low
$4.82
PE Ratio
-3.22
OPTN Fundamentals
Price
$9.60
Prev Close
$9.71
Open
$9.67
50D MA
$9.34
Beta
0.42
Avg. Volume
60,009.81
EPS (Annual)
-$2.12
P/B
-1.58
Rev/Employee
$611,140.63
Loading...
Loading...
News
all
press releases
News Placeholder
OptiNose (OPTN) Reports Q1 Loss, Tops Revenue Estimates
Zacks·7mo ago
News Placeholder
Karyopharm Therapeutics (KPTI) Reports Q1 Loss, Lags Revenue Estimates
Zacks·7mo ago
News Placeholder
Crinetics Pharmaceuticals, Inc. (CRNX) Reports Q1 Loss, Tops Revenue Estimates
chainwire·7mo ago
News Placeholder
Optinose Shares Soar After Merger Agreement With Paratek Pharmaceuticals: Retail Sentiment Takes Flight
Paratek will acquire Optinose's outstanding shares for $9 apiece in cash, representing a 50% premium to the stock’s closing trading price of $6 on March 19, and up to $5 per share in contingent value rights if XHANCE achieves certain net revenue milestones.
Stocktwits·9mo ago
<
...
1
>

Latest OPTN News

View

Advertisement|Remove ads.

Advertisement|Remove ads.